Study Offers Promise for Multicancer Detection from a Single Blood Draw
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read MorePosted by | Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types |
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read MorePosted by | Mar 31, 2020 | Computing Systems, Information Technology, Middleware & Software |
Qlucore is expanding its bioinformatics software business into precision medicine and precision diagnostics.
Read MorePosted by | Mar 16, 2020 | Cancer, Molecular Diagnostics |
Thermo Fisher Scientific will collaborate with Janssen scientists to validate multiple biomarkers, which will be used to identify variant-positive patients for enrollment into clinical trials focused on non-small cell lung cancer.
Read MorePosted by Steve Halasey | Feb 27, 2020 | Sepsis, Uncategorized |
Sperzel succeeds John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read MorePosted by | Jan 27, 2020 | Lung Cancer |
Targeted cancer treatment using an ALK inhibitor in combination with a PIM1 inhibitor can increase the chances of survival of children with an unfavorable prognosis.
Read More